Paper42100295
CERV-Score: A Hybrid Machine Learning Framework for Cervical Cancer Risk Prediction Using Integrated Clinical and Genomic Data.
Alanazi AM and 1 other. Int J Telemed Appl, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. CERV-Score: A Hybrid Machine Learning Framework for Cervical Cancer Risk Prediction Using Integrated Clinical and Genomic Data. Papers, record 42100295. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42100295
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CERV-Score: A Hybrid Machine Learning Framework for Cervical Cancer Risk Prediction Using Integrated Clinical and Genomic Data.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39738223 | Bidirectional recurrent neural network approach for predicting cervical cancer recurrence and survival. | Sci Rep | 2024 | https://conductscience.org/library/papers/39738223 | PubMed |
| 2 | 35004588 | Machine Learning Assisted Cervical Cancer Detection. | Front Public Health | 2021 | https://conductscience.org/library/papers/35004588 | PubMed |
| 3 | 21045064 | CCDB: a curated database of genes involved in cervix cancer. | Nucleic Acids Res | 2011 | https://conductscience.org/library/papers/21045064 | PubMed |
| 4 | 33548541 | Obtaining EHR-derived datasets for COVID-19 research within a short time: a flexible methodology based on Detailed Clinical Models. | J Biomed Inform | 2021 | https://conductscience.org/library/papers/33548541 | PubMed |
| 5 | 33798717 | Creating and implementing a COVID-19 recruitment Data Mart. | J Biomed Inform | 2021 | https://conductscience.org/library/papers/33798717 | PubMed |
| 6 | 39060960 | Identification of key genes associated with cervical cancer based on bioinformatics analysis. | BMC Cancer | 2024 | https://conductscience.org/library/papers/39060960 | PubMed |
| 7 | 38133443 | Prevalence of Human Papillomavirus Infection and Cervical Abnormalities among Women Attending a Tertiary Care Center in Saudi Arabia over 2 Years. | Trop Med Infect Dis | 2023 | https://conductscience.org/library/papers/38133443 | PubMed |
| 8 | 38143659 | Prevalence and Predictive Factors of Cervical Cancer Screening in Saudi Arabia: A Nationwide Study. | Cureus | 2023 | https://conductscience.org/library/papers/38143659 | PubMed |
| 9 | 36292449 | Cervical Cancer Diagnosis Using an Integrated System of Principal Component Analysis, Genetic Algorithm, and Multilayer Perceptron. | Healthcare (Basel) | 2022 | https://conductscience.org/library/papers/36292449 | PubMed |
| 10 | 42100295 | CERV-Score: A Hybrid Machine Learning Framework for Cervical Cancer Risk Prediction Using Integrated Clinical and Genomic Data. | Int J Telemed Appl | 2026 | https://conductscience.org/library/papers/42100295 | PubMed |
| 11 | 35572826 | Hybrid Model for Detection of Cervical Cancer Using Causal Analysis and Machine Learning Techniques. | Comput Math Methods Med | 2022 | https://conductscience.org/library/papers/35572826 | PubMed |
| 12 | 32429090 | Data-Driven Cervical Cancer Prediction Model with Outlier Detection and Over-Sampling Methods. | Sensors (Basel) | 2020 | https://conductscience.org/library/papers/32429090 | PubMed |
| 13 | 38455474 | A multi-variable predictive warning model for cervical cancer using clinical and SNPs data. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/38455474 | PubMed |
| 14 | 35924232 | A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes. | Front Immunol | 2022 | https://conductscience.org/library/papers/35924232 | PubMed |
| 15 | 37055741 | Cervical cancer survival prediction by machine learning algorithms: a systematic review. | BMC Cancer | 2023 | https://conductscience.org/library/papers/37055741 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42100295 | CERV-Score: A Hybrid Machine Learning Framework for Cervical Cancer Risk Prediction Using Integrated Clinical and Genomic Data. | Int J Telemed Appl | 2026 | https://conductscience.org/library/papers/42100295 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42100295
GET https://conductscience.org/api/papers/v1/42100295/authors